Company Information
Industry News
02/11 .2025
Biominhai Collaborates with Dek Vaccines for 13-Valent PCV Technology Transfer and Drug Supply
08/25 .2025
New to BioKangtai R&D Pipeline: Klebsiella pneumoniae Vaccine
BioKangtai Celebrates a Significant Milestone Achievement
05/27 .2025
Join Us at CPHI China 2025 （#W4G66）
04/27 .2025
BioKangtai Advances Oral Pentavalent Rotavirus Vaccine to Phase III Clinical Trial
04/03 .2025
BioKangtai: 20-Valent Pneumococcal Vaccine Enters Phase II Clinical Trial
BioKangtai and AstraZeneca Announce Strategic Partnership to Advance Global Vaccine Innovation
